Adakveo and Acetaminophen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Adakveo (crizanlizumab-tmca) and Acetaminophen (acetaminophen). Common drug interactions include skin lesion among females and chest pain among males.

The phase IV clinical study analyzes what interactions people have when they take Adakveo and Acetaminophen. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Adakveo?

Adakveo has active ingredients of crizanlizumab-tmca. eHealthMe is studying from 1,585 Adakveo users. Check the latest studies of Adakveo.

What is Acetaminophen?

Acetaminophen has active ingredients of acetaminophen. It is often used in pain. eHealthMe is studying from 183,077 Acetaminophen users. Check the latest studies of Acetaminophen.



On Jul, 15, 2026

14 people who take Adakveo and Acetaminophen together, and have interactions are studied.

Adakveo and Acetaminophen drug interactions.

What are the common drug interactions of Adakveo and Acetaminophen, by gender? *:

female:

  1. Skin lesion

male:

  1. Chest pain
  2. Acute chest syndrome (acute chest pain, fever and difficulty breathing)
  3. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  4. Anaemia (lack of blood)
  5. Complement factor increased
  6. Dyspnoea (difficult or laboured respiration)
  7. Hypersensitivity
  8. Hypertransaminasaemia
  9. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
  10. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

What are the common drug interactions of Adakveo and Acetaminophen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Anaemia (lack of blood)

10-19:

  1. Chest pain
  2. Pain in extremity
  3. Acute chest syndrome (acute chest pain, fever and difficulty breathing)
  4. Arthralgia (joint pain)
  5. Back pain
  6. Complement factor increased
  7. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
  8. Hypersensitivity
  9. Hypertransaminasaemia
  10. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)

20-29:

  1. Acute chest syndrome (acute chest pain, fever and difficulty breathing)
  2. Back pain
  3. Chest pain
  4. Dyspnoea (difficult or laboured respiration)
  5. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  6. Tachypnoea (a condition of rapid breathing over 20 per minute)
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

30-39:

  1. Chest pain
  2. Cough
  3. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
  4. Pain in extremity
  5. Pneumonia
  6. Pyrexia (fever)
  7. Skin lesion

40-49:

n/a

50-59:

  1. Arthralgia (joint pain)
  2. Cardiac arrest
  3. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)

60+:

n/a

What are the existing conditions these people have? *

  1. Constipation: 3 people, 21.43%
  2. Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 2 people, 14.29%
  3. Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 14.29%
  4. Dysmenorrhea (painful menstruation): 2 people, 14.29%
  5. Birth Control: 2 people, 14.29%
  6. Rickets (softening of bones): 1 person, 7.14%
  7. Migraine (headache): 1 person, 7.14%
  8. Headache (pain in head): 1 person, 7.14%
  9. Cough: 1 person, 7.14%
  10. Cardiomyopathy (weakening of the heart muscle): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Adakveo and Acetaminophen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Adakveo and Acetaminophen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Adakveo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Acetaminophen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Adakveo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acetaminophen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on crizanlizumab-tmca and acetaminophen (the active ingredients of Adakveo and Acetaminophen, respectively), and Adakveo and Acetaminophen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: